| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |